Drug needs of the sheep industry

Area of Science:

• Veterinary Pharmacology
• Animal Science
• Reproductive Biology

Background:

• The U.S. sheep industry faces challenges in production efficiency and disease management.
• Existing pharmaceutical options for sheep are limited in scope and efficacy.
• There is a need for improved reproductive and therapeutic drugs in sheep production.

Purpose of the Study:

• To review critical drug needs within the sheep industry.
• To identify requirements for prolificacy-enhancing drugs.
• To outline necessary advancements in disease prevention and treatment drugs for sheep.

Main Methods:

• Literature review of current sheep industry drug needs.
• Analysis of existing drug approvals and limitations for sheep.
• Identification of key areas for pharmaceutical development in sheep.

Main Results:

• Identified need for prolificacy drugs to improve out-of-season lambing and lambing rates.
• Highlighted demand for effective treatments for abortion, neonatal diarrhea, pneumonia, and internal parasites.
• Noted lack of approved, safe, or effective dosage-level drugs for critical sheep diseases.

Conclusions:

• Development of novel prolificacy drugs is essential for genetic improvement and management.
• Availability of efficacious and safe drugs for major sheep diseases is crucial for industry health.
• Addressing these drug needs will enhance U.S. sheep industry productivity and market competitiveness.